Versant (VSNT) Financials

Versant logo
$36.04 -0.36 (-0.99%)
As of 03:48 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Versant

Annual Income Statements for Versant

This table shows Versant's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,539 1,363 930
Consolidated Net Income / (Loss)
1,540 1,365 931
Net Income / (Loss) Continuing Operations
1,539 1,365 931
Total Pre-Tax Income
2,069 1,843 1,228
Total Operating Income
2,069 1,841 1,272
Total Gross Profit
7,445 7,062 6,688
Total Revenue
7,445 7,062 6,688
Operating Revenue
7,445 7,062 6,688
Total Cost of Revenue
0.00 0.00 0.00
Total Operating Expenses
5,376 5,220 5,416
Selling, General & Admin Expense
1,231 1,167 1,469
Depreciation Expense
991 989 1,010
Other Operating Expenses / (Income)
3,154 3,064 2,937
Total Other Income / (Expense), net
0.00 1.00 -44
Interest Expense
0.00 0.00 13
Other Income / (Expense), net
0.00 1.00 -31
Income Tax Expense
530 478 297
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 2.00 1.00
Weighted Average Basic Shares Outstanding
- - 144.17M
Weighted Average Diluted Shares Outstanding
- - 144.17M
Weighted Average Basic & Diluted Shares Outstanding
- - 144.17M

Quarterly Income Statements for Versant

This table shows Versant's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
367 302 80 286 211 47
Consolidated Net Income / (Loss)
367 303 79 286 211 47
Net Income / (Loss) Continuing Operations
367 303 79 286 211 46
Total Pre-Tax Income
499 409 124 398 323 66
Total Operating Income
499 410 164 442 367 110
Total Gross Profit
1,706 1,008 1,663 1,687 994 1,594
Total Revenue
1,706 1,708 1,663 1,687 1,644 1,594
Operating Revenue
1,706 1,708 1,663 1,687 1,644 1,594
Total Cost of Revenue
0.00 700 0.00 0.00 650 0.00
Total Operating Expenses
1,206 599 1,500 1,245 627 1,484
Selling, General & Admin Expense
307 355 372 351 369 362
Depreciation Expense
245 244 255 256 258 243
Other Operating Expenses / (Income)
654 - 873 638 - 879
Total Other Income / (Expense), net
0.00 -1.00 -39 -44 -43 -45
Interest Expense
0.00 0.00 0.00 52 52 53
Other Income / (Expense), net
0.00 -1.00 -39 8.00 9.00 8.00
Income Tax Expense
132 106 45 112 112 19
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 1.00 -1.00 0.00 0.00 0.00
Basic Earnings per Share
$2.55 $2.09 $0.56 $1.99 $1.50 $0.34
Weighted Average Basic Shares Outstanding
- - - 141.50M 139.17M 136.69M
Diluted Earnings per Share
$2.55 $2.09 $0.56 $1.99 $1.49 $0.34
Weighted Average Diluted Shares Outstanding
- - - 141.50M 139.17M 136.69M
Weighted Average Basic & Diluted Shares Outstanding
- - - 141.50M 139.17M 136.69M

Annual Cash Flow Statements for Versant

This table details how cash moves in and out of Versant's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
13 -16 1,084
Net Cash From Operating Activities
2,428 2,211 2,022
Net Cash From Continuing Operating Activities
2,429 2,211 2,022
Net Income / (Loss) Continuing Operations
1,540 1,365 931
Consolidated Net Income / (Loss)
1,540 1,365 931
Depreciation Expense
991 989 1,010
Non-Cash Adjustments To Reconcile Net Income
171 84 169
Changes in Operating Assets and Liabilities, net
-273 -227 -88
Net Cash From Investing Activities
-60 -71 -155
Net Cash From Continuing Investing Activities
-60 -71 -155
Purchase of Property, Plant & Equipment
-56 -54 -167
Acquisitions
0.00 0.00 -24
Other Investing Activities, net
-4.00 -17 36
Net Cash From Financing Activities
-2,355 -2,155 -782
Net Cash From Continuing Financing Activities
-2,355 -2,154 -782
Repayment of Debt
4.00 -12 -23
Issuance of Debt
0.00 0.00 986
Other Financing Activities, net
-2,359 -2,142 -1,745

Quarterly Cash Flow Statements for Versant

This table details how cash moves in and out of Versant's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-3.00 -1.00 51 104 282 -427
Net Cash From Operating Activities
478 635 433 585 382 346
Net Cash From Continuing Operating Activities
476 637 432 585 382 346
Net Income / (Loss) Continuing Operations
367 303 79 286 211 47
Consolidated Net Income / (Loss)
367 303 79 286 211 47
Depreciation Expense
245 244 255 256 258 243
Amortization Expense
0.00 - - 3.00 2.00 3.00
Non-Cash Adjustments To Reconcile Net Income
38 42 45 87 16 33
Changes in Operating Assets and Liabilities, net
-174 48 53 -47 -105 20
Net Cash From Investing Activities
-23 -54 -9.00 -172 53 -590
Net Cash From Continuing Investing Activities
-23 -54 -9.00 -172 54 -591
Purchase of Property, Plant & Equipment
-21 -42 -58 -27 -32 -44
Acquisitions
0.00 - - -145 -54 -497
Net Cash From Financing Activities
-458 -582 -373 -309 -153 -183
Net Cash From Continuing Financing Activities
-457 -583 -373 -309 -153 -183
Repayment of Debt
-3.00 -9.00 - -2.00 - -30
Repurchase of Common Equity
0.00 - - -100 -100 -100
Payment of Dividends
- - - - - -53

Annual Balance Sheets for Versant

This table presents Versant's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2025
Period end date 12/31/2024 12/31/2025
Total Assets
12,049 12,333
Total Current Assets
1,318 2,502
Cash & Equivalents
8.00 55
Restricted Cash
0.00 1,034
Accounts Receivable
1,245 1,151
Other Current Assets
65 66
Other Current Nonoperating Assets
0.00 196
Plant, Property, & Equipment, net
143 423
Total Noncurrent Assets
10,588 9,408
Long-Term Investments
254 214
Goodwill
7,732 7,611
Intangible Assets
1,869 924
Other Noncurrent Operating Assets
733 659
Total Liabilities & Shareholders' Equity
12,049 12,333
Total Liabilities
1,134 1,931
Total Current Liabilities
590 622
Short-Term Debt
- 0.00
Accounts Payable
102 151
Accrued Expenses
111 141
Current Deferred Revenue
135 163
Current Employee Benefit Liabilities
43 62
Other Current Liabilities
198 105
Total Noncurrent Liabilities
544 1,309
Long-Term Debt
0.00 983
Noncurrent Deferred & Payable Income Tax Liabilities
428 191
Other Noncurrent Operating Liabilities
116 135
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
10,915 10,402
Total Preferred & Common Equity
10,797 10,292
Preferred Stock
- 0.00
Total Common Equity
10,797 10,292
Common Stock
- 0.00
Retained Earnings
- 0.00
Accumulated Other Comprehensive Income / (Loss)
-8.00 -7.00
Other Equity Adjustments
10,805 10,299
Noncontrolling Interest
118 110

Quarterly Balance Sheets for Versant

This table presents Versant's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2026 6/30/2026 9/30/2026
Total Assets
12,506 12,740 12,656
Total Current Assets
2,650 2,937 2,493
Cash & Equivalents
1,193 1,478 1,051
Restricted Cash
0.00 0.00 0.00
Accounts Receivable
1,193 1,326 1,241
Other Current Assets
82 133 201
Other Current Nonoperating Assets
181 0.00 0.00
Plant, Property, & Equipment, net
424 441 463
Total Noncurrent Assets
9,432 9,362 9,699
Long-Term Investments
241 248 262
Goodwill
7,707 7,804 8,127
Intangible Assets
713 499 482
Other Noncurrent Operating Assets
771 811 828
Total Liabilities & Shareholders' Equity
12,506 12,740 12,656
Total Liabilities
4,361 4,516 4,509
Total Current Liabilities
1,140 1,234 1,196
Short-Term Debt
83 113 113
Accounts Payable
283 268 224
Accrued Expenses
434 425 383
Current Deferred Revenue
77 83 97
Current Employee Benefit Liabilities
84 100 153
Other Current Liabilities
180 245 226
Total Noncurrent Liabilities
3,221 3,282 3,313
Long-Term Debt
2,869 2,841 2,813
Noncurrent Deferred & Payable Income Tax Liabilities
115 110 152
Other Noncurrent Operating Liabilities
237 331 348
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
8,145 8,224 8,147
Total Preferred & Common Equity
8,034 8,114 8,037
Preferred Stock
0.00 0.00 0.00
Total Common Equity
8,034 8,113 8,036
Common Stock
7,807 7,724 7,638
Retained Earnings
231 388 382
Accumulated Other Comprehensive Income / (Loss)
-4.00 1.00 16
Other Equity Adjustments
0.00 0.00 0.00
Noncontrolling Interest
110 111 110

Annual Metrics And Ratios for Versant

This table displays calculated financial ratios and metrics derived from Versant's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 0.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00
Growth Metrics
- - -
Revenue Growth
0.00% -5.14% -5.30%
EBITDA Growth
0.00% -7.48% -20.49%
EBIT Growth
0.00% -10.97% -32.63%
NOPAT Growth
0.00% -11.40% -29.27%
Net Income Growth
0.00% -11.36% -31.79%
EPS Growth
0.00% 0.00% 0.00%
Operating Cash Flow Growth
0.00% -8.94% -8.55%
Free Cash Flow Firm Growth
0.00% 0.00% 118.65%
Invested Capital Growth
0.00% 0.00% -7.21%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00%
Profitability Metrics
- - -
Gross Margin
100.00% 100.00% 100.00%
EBITDA Margin
41.10% 40.09% 33.66%
Operating Margin
27.79% 26.07% 19.02%
EBIT Margin
27.79% 26.08% 18.56%
Profit (Net Income) Margin
20.69% 19.33% 13.92%
Tax Burden Percent
74.43% 74.06% 75.81%
Interest Burden Percent
100.00% 100.05% 98.95%
Effective Tax Rate
25.62% 25.94% 24.19%
Return on Invested Capital (ROIC)
0.00% 25.60% 9.39%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 24.46% 17.98%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.58% -0.66%
Return on Equity (ROE)
0.00% 25.01% 8.73%
Cash Return on Invested Capital (CROIC)
0.00% -174.40% 16.87%
Operating Return on Assets (OROA)
0.00% 15.29% 10.18%
Return on Assets (ROA)
0.00% 11.33% 7.64%
Return on Common Equity (ROCE)
0.00% 24.74% 8.64%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,539 1,364 964
NOPAT Margin
20.67% 19.31% 14.42%
Net Nonoperating Expense Percent (NNEP)
0.00% 1.14% -8.59%
Return On Investment Capital (ROIC_SIMPLE)
- 12.49% 8.47%
Cost of Revenue to Revenue
0.00% 0.00% 0.00%
SG&A Expenses to Revenue
16.53% 16.53% 21.96%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
72.21% 73.92% 80.98%
Earnings before Interest and Taxes (EBIT)
2,069 1,842 1,241
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,060 2,831 2,251
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.00 0.00 0.09
Long-Term Debt to Equity
0.00 0.00 0.09
Financial Leverage
0.00 -0.02 -0.04
Leverage Ratio
0.00 1.10 1.14
Compound Leverage Factor
0.00 1.10 1.13
Debt to Total Capital
0.00% 0.00% 8.63%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 8.63%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.08% 0.97%
Common Equity to Total Capital
0.00% 98.92% 90.40%
Debt to EBITDA
0.00 0.00 0.44
Net Debt to EBITDA
0.00 0.00 -0.14
Long-Term Debt to EBITDA
0.00 0.00 0.44
Debt to NOPAT
0.00 0.00 1.02
Net Debt to NOPAT
0.00 0.00 -0.33
Long-Term Debt to NOPAT
0.00 0.00 1.02
Altman Z-Score
0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 1.08% 1.07%
Liquidity Ratios
- - -
Current Ratio
0.00 2.23 4.02
Quick Ratio
0.00 2.12 1.94
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -9,290 1,732
Operating Cash Flow to CapEx
4,335.71% 4,094.44% 1,210.78%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 133.26
Operating Cash Flow to Interest Expense
0.00 0.00 155.54
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 142.69
Efficiency Ratios
- - -
Asset Turnover
0.00 0.59 0.55
Accounts Receivable Turnover
0.00 5.67 5.58
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
0.00 49.38 23.63
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 64.35 65.38
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 64.35 65.38
Capital & Investment Metrics
- - -
Invested Capital
0.00 10,654 9,886
Invested Capital Turnover
0.00 1.33 0.65
Increase / (Decrease) in Invested Capital
0.00 10,654 -768
Enterprise Value (EV)
0.00 0.00 0.00
Market Capitalization
0.00 0.00 0.00
Book Value per Share
$0.00 $0.00 $71.39
Tangible Book Value per Share
$0.00 $0.00 $12.19
Total Capital
0.00 10,915 11,385
Total Debt
0.00 0.00 983
Total Long-Term Debt
0.00 0.00 983
Net Debt
0.00 -262 -320
Capital Expenditures (CapEx)
56 54 167
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 720 791
Debt-free Net Working Capital (DFNWC)
0.00 728 1,880
Net Working Capital (NWC)
0.00 728 1,880
Net Nonoperating Expense (NNE)
-1.00 -1.48 33
Net Nonoperating Obligations (NNO)
0.00 -261 -516
Total Depreciation and Amortization (D&A)
991 989 1,010
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 10.20% 11.83%
Debt-free Net Working Capital to Revenue
0.00% 10.31% 28.11%
Net Working Capital to Revenue
0.00% 10.31% 28.11%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 144.17M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 144.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 144.17M
Normalized Net Operating Profit after Tax (NOPAT)
1,539 1,364 964
Normalized NOPAT Margin
20.67% 19.31% 14.42%
Pre Tax Income Margin
27.79% 26.10% 18.36%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 95.46
NOPAT to Interest Expense
0.00 0.00 74.18
EBIT Less CapEx to Interest Expense
0.00 0.00 82.62
NOPAT Less CapEx to Interest Expense
0.00 0.00 61.34
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Versant

This table displays calculated financial ratios and metrics derived from Versant's official financial filings.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
0.00 0.00 0.00 144,168,616.00 141,498,015.00 139,170,078.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 144,168,616.00 141,498,015.00 139,170,078.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 1.98 1.49 0.34
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% 0.00% -1.11% -3.75% -4.15%
EBITDA Growth
0.00% 0.00% 0.00% -4.70% -2.60% -4.21%
EBIT Growth
0.00% 0.00% 0.00% -9.82% -8.07% -5.60%
NOPAT Growth
0.00% 0.00% 0.00% -13.46% -21.07% -25.03%
Net Income Growth
0.00% 0.00% 0.00% -22.07% -30.36% -40.51%
EPS Growth
0.00% 0.00% 0.00% -21.96% -28.71% -39.29%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 22.38% -39.84% -20.09%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 0.12% -2.63% 0.00% -2.55% -3.04%
EBITDA Q/Q Growth
0.00% -12.23% -41.81% 0.00% -10.30% -42.77%
EBIT Q/Q Growth
0.00% -18.04% -69.44% 0.00% -16.44% -68.62%
NOPAT Q/Q Growth
0.00% -17.24% -65.60% 0.00% -24.52% -67.33%
Net Income Q/Q Growth
0.00% -17.44% -73.93% 0.00% -26.22% -77.73%
EPS Q/Q Growth
0.00% -18.04% -73.21% 0.00% -25.13% -77.18%
Operating Cash Flow Q/Q Growth
0.00% 32.85% -31.81% 0.00% -34.70% -9.42%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -0.54% -5.08%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% -0.30% 3.25%
Profitability Metrics
- - - - - -
Gross Margin
100.00% 59.02% 100.00% 100.00% 60.46% 100.00%
EBITDA Margin
43.61% 38.23% 22.85% 42.03% 38.69% 22.84%
Operating Margin
29.25% 24.00% 9.86% 26.20% 22.32% 6.90%
EBIT Margin
29.25% 23.95% 7.52% 26.67% 22.87% 7.40%
Profit (Net Income) Margin
21.51% 17.74% 4.75% 16.95% 12.83% 2.95%
Tax Burden Percent
73.55% 74.08% 63.71% 71.86% 65.33% 71.21%
Interest Burden Percent
100.00% 100.00% 99.20% 88.44% 85.90% 55.93%
Effective Tax Rate
26.45% 25.92% 36.29% 28.14% 34.67% 28.79%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 26.49% 20.38% 6.58%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 21.75% 15.70% 2.70%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 3.57% 2.34% 0.53%
Return on Equity (ROE)
0.00% 0.00% 0.00% 30.05% 22.73% 7.12%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 14.22% 11.86% 3.82%
Return on Assets (ROA)
0.00% 0.00% 0.00% 9.04% 6.65% 1.52%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 29.65% 22.42% 7.02%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
367 304 104 318 240 78
NOPAT Margin
21.51% 17.78% 6.28% 18.83% 14.58% 4.91%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 4.74% 4.68% 3.89%
Return On Investment Capital (ROIC_SIMPLE)
- - - 2.86% 2.14% 0.71%
Cost of Revenue to Revenue
0.00% 40.98% 0.00% 0.00% 39.54% 0.00%
SG&A Expenses to Revenue
18.00% 20.78% 22.37% 20.81% 22.45% 22.71%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
70.69% 35.07% 90.20% 73.80% 38.14% 93.10%
Earnings before Interest and Taxes (EBIT)
499 409 125 450 376 118
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
744 653 380 709 636 364
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.64 0.61 0.53
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.77 0.75 0.66
Price to Earnings (P/E)
0.00 0.00 0.00 6.04 6.54 5.91
Dividend Yield
0.00% 0.00% 0.00% 0.00% 1.05% 2.39%
Earnings Yield
0.00% 0.00% 0.00% 16.55% 15.28% 16.93%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.71 0.67 0.62
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 1.01 0.95 0.92
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 3.05 2.87 2.76
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 5.67 5.43 5.21
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 7.38 7.38 7.27
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 3.17 3.36 3.36
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.36 0.36 0.36
Long-Term Debt to Equity
0.00 0.00 0.00 0.35 0.35 0.35
Financial Leverage
0.00 0.00 0.00 0.16 0.15 0.20
Leverage Ratio
0.00 0.00 0.00 1.54 1.55 1.55
Compound Leverage Factor
0.00 0.00 0.00 1.36 1.33 0.87
Debt to Total Capital
0.00% 0.00% 0.00% 26.60% 26.43% 26.42%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.75% 1.01% 1.02%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 25.85% 25.42% 25.40%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.99% 0.99% 0.99%
Common Equity to Total Capital
0.00% 0.00% 0.00% 72.40% 72.58% 72.57%
Debt to EBITDA
0.00 0.00 0.00 1.33 1.35 1.35
Net Debt to EBITDA
0.00 0.00 0.00 0.69 0.56 0.74
Long-Term Debt to EBITDA
0.00 0.00 0.00 1.30 1.29 1.29
Debt to NOPAT
0.00 0.00 0.00 3.22 3.46 3.54
Net Debt to NOPAT
0.00 0.00 0.00 1.66 1.44 1.95
Long-Term Debt to NOPAT
0.00 0.00 0.00 3.13 3.33 3.41
Altman Z-Score
0.00 0.00 0.00 1.53 1.48 1.28
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 1.36% 1.35% 1.36%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 0.00 0.00 2.32 2.38 2.08
Quick Ratio
0.00 0.00 0.00 2.09 2.27 1.92
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 -9,162 -9,212 -9,681
Operating Cash Flow to CapEx
2,276.19% 1,511.90% 746.55% 2,166.67% 1,193.75% 786.36%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 -176.20 -177.16 -182.65
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 11.25 7.35 6.53
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 10.73 6.73 5.70
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.00 0.00 0.53 0.52 0.52
Accounts Receivable Turnover
0.00 0.00 0.00 5.59 4.98 5.27
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 15.73 14.98 14.12
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 65.29 73.28 69.30
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 65.29 73.28 69.30
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 0.00 0.00 9,480 9,452 9,759
Invested Capital Turnover
0.00 0.00 0.00 1.41 1.40 1.34
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 9,480 9,452 9,759
Enterprise Value (EV)
0.00 0.00 0.00 6,759 6,298 6,005
Market Capitalization
0.00 0.00 0.00 5,131 4,959 4,282
Book Value per Share
$0.00 $0.00 $0.00 $55.73 $57.34 $57.74
Tangible Book Value per Share
$0.00 $0.00 $0.00 ($2.68) ($1.34) ($4.12)
Total Capital
0.00 0.00 0.00 11,097 11,178 11,073
Total Debt
0.00 0.00 0.00 2,952 2,954 2,926
Total Long-Term Debt
0.00 0.00 0.00 2,869 2,841 2,813
Net Debt
0.00 0.00 0.00 1,518 1,228 1,613
Capital Expenditures (CapEx)
21 42 58 27 32 44
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 400 338 359
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 1,593 1,816 1,410
Net Working Capital (NWC)
0.00 0.00 0.00 1,510 1,703 1,297
Net Nonoperating Expense (NNE)
0.00 0.74 25 32 29 31
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 1,335 1,228 1,612
Total Depreciation and Amortization (D&A)
245 244 255 259 260 246
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 6.00% 5.12% 5.49%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 23.89% 27.49% 21.57%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 22.64% 25.78% 19.84%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $1.99 $1.50 $0.34
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 141.50M 139.17M 136.69M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $1.99 $1.49 $0.34
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 141.50M 139.17M 136.69M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 141.50M 139.17M 136.69M
Normalized Net Operating Profit after Tax (NOPAT)
367 304 104 318 240 78
Normalized NOPAT Margin
21.51% 17.78% 6.28% 18.83% 14.58% 4.91%
Pre Tax Income Margin
29.25% 23.95% 7.46% 23.59% 19.65% 4.14%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 8.65 7.23 2.23
NOPAT to Interest Expense
0.00 0.00 0.00 6.11 4.61 1.48
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 8.13 6.62 1.40
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 5.59 4.00 0.65
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Versant’s Q2 2026 results show weaker profitability and cash generation despite a stronger balance sheet. The available data covers Q1 2025 through Q2 2026, rather than a full four-year period. Year over year, revenue declined 3.7% to $1.64 billion, while net income attributable to common shareholders fell 30.1% to $211 million. Diluted EPS decreased to $1.49 from $2.09.

Revenue pressure was partly offset by lower reported cost of revenue. Gross profit declined only 1.4% to $994 million, and the gross margin improved to approximately 60.5% from 59.0%. However, operating income fell 10.5% to $367 million, as depreciation increased and operating expenses remained substantial. Operating margin narrowed to approximately 22.3% from 24.0%.

Cash generation weakened considerably. Operating cash flow fell 39.8% year over year to $382 million and declined from $585 million in Q1 2026. The $105 million use of cash from operating assets and liabilities in Q2 also compares unfavorably with a $48 million source of cash in the year-ago quarter.

  • Strong liquidity: Cash and equivalents increased to $1.48 billion at June 30, 2026, up from $1.19 billion at the end of Q1. Current assets of $2.94 billion exceeded current liabilities of $1.23 billion by a wide margin.
  • Improved gross margin: Q2 gross margin increased to approximately 60.5% from 59.0% a year earlier, indicating that cost of revenue declined faster than revenue.
  • Positive operating cash flow: Versant generated $382 million in operating cash flow in Q2, providing internal funding for capital spending, acquisitions, dividends and share repurchases.
  • Share count reduction: Weighted average diluted shares declined to approximately 139.2 million from 141.5 million in Q1 2026, helped by a $100 million common-stock repurchase during Q2.
  • Stable reported debt: Short- and long-term debt totaled approximately $2.95 billion at both the end of Q1 and Q2 2026. Debt was therefore broadly unchanged sequentially, but interest expense of $52 million reduced pretax earnings.
  • Consistent dividend: The quarterly cash dividend remained $0.375 per share in both Q1 and Q2 2026, providing income for shareholders while also representing an ongoing cash commitment.
  • Revenue contraction: Q2 revenue declined 3.7% year over year and 2.5% sequentially, extending the softer top-line trend seen in the reported quarters.
  • Profitability deterioration: Net income attributable to common shareholders fell 30.1% year over year, while diluted EPS dropped 28.7% to $1.49. Net income also declined from $286 million in Q1 2026.
  • Lower cash conversion: Operating cash flow fell nearly 40% from the prior-year quarter and 34.7% sequentially, a sharper decline than revenue and a potential concern if the trend persists.
  • High goodwill concentration: Goodwill totaled $7.80 billion, representing approximately 61% of total assets. This concentration increases impairment risk if acquired businesses underperform or industry conditions weaken.

Overall, Versant retains substantial liquidity, positive operating cash flow and a manageable near-term liquidity position. However, the year-over-year declines in revenue, earnings and cash generation are notable, particularly because Q2 2026 also included higher interest expense and continued capital allocation through dividends and buybacks. Investors should monitor whether the improved gross margin can offset weaker revenue and operating cash flow in subsequent quarters.

11/18/26 03:43 PM ETAI Generated. May Contain Errors.

Versant Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Versant's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Versant's net income appears to be on a downward trend, with a most recent value of $931 million in 2025, falling from $1.54 billion in 2023. The previous period was $1.37 billion in 2024. See Versant's forecast for analyst expectations on what's next for the company.

Versant's total operating income in 2025 was $1.27 billion, based on the following breakdown:
  • Total Gross Profit: $6.69 billion
  • Total Operating Expenses: $5.42 billion

Over the last 2 years, Versant's total revenue changed from $7.45 billion in 2023 to $6.69 billion in 2025, a change of -10.2%.

In the past 2 quarters, Versant's cash and equivalents has ranged from $1.05 billion in Q3 2026 to $1.48 billion in Q2 2026, and is currently $1.05 billion as of their latest financial filing in Q3 2026.

Versant had total debt of $983 million at the end of 2025, compared with none in 2024, and none in 2023.

Over the last 2 years, Versant's book value per share changed from 0.00 in 2023 to 71.39 in 2025, a change of 7,138.9%.



Financial statements for NASDAQ:VSNT last updated on 11/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners